Program
HRS-9190
A development code. Also written as “HRS-9190; under Inhalational Anesthesia”, “HRS-9190; under Intravenous Anesthesia” and “[14C] HRS-9190”.
In Jiangsu HengRui Medicine's pipeline, nAChR
. Its studies are led by Jiangsu HengRui Medicine.
Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Jiangsu HengRui Medicine | 72 open or running | phase 3since Jul 31, 2026 | Apr 10, 2025 | Dec 31, 2026phase 3 · NCT07746726 |
- Named in Jiangsu HengRui Medicine’s own pipeline as
HRS-9190
, phase 3, as of Jul 31, 2026 (source).
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Apr 10, 2025First study: phase 1 study in Skeletal Muscle RelaxationFirst studyNCT06932315 · 53 enrolled · China
- Aug 8, 2025Phase 1 study in Skeletal Muscle RelaxationNCT07142850 · 49 enrolled · China
- Nov 14, 2025Phase 2 study in Neuromuscular BlockadeNCT07252921 · 70 enrolled · China
- Feb 5, 20262 phase 2 studies in Neuromuscular BlockadeNCT07404579, NCT07446309
- Mar 16, 2026Phase 1 study in Healthy Adult MaleNCT07494175 · 6 enrolled · China
- Jul 31, 2026Phase 3 study in Neuromuscular BlockadePhase 3 reachedNCT07746726 · 320 planned · China
Ahead
- Dec 31, 2026Primary completion: phase 3 study in Neuromuscular BlockadeNCT07746726
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 7 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07746726Neuromuscular Blockade · China | 3 | Recruiting | Dec 31, 2026 | 320 |
| NCT07494175Healthy Adult Male · China | 1 | Active, not recruiting | May 2026 | 6 |
| NCT07446309Neuromuscular Blockade · China | 2 | Completed | Jul 14, 2026 | 67 |
| NCT07404579Neuromuscular Blockade · China | 2 | Completed | May 15, 2026 | 103 |
| NCT07252921Neuromuscular Blockade · China | 2 | Completed | Dec 30, 2025 | 70 |
| NCT07142850Skeletal Muscle Relaxation · China | 1 | Completed | Oct 31, 2025 | 49 |
| NCT06932315Skeletal Muscle Relaxation · China | 1 | Completed | Aug 13, 2025 | 53 |
How it is read
Names in the registry
- “HRS-9190”, 9 entries
- “HRS-9190; under Inhalational Anesthesia”, 1 entry
- “HRS-9190; under Intravenous Anesthesia”, 1 entry
- “[14C] HRS-9190”, 1 entry
- “HRS-9190 for Injection”, 1 entry
Codes read as this program: HRS9190.
Conditions, from the studies’ own filings
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.